Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$72,691,165
+$3,189,288 QoQ
Shares Held
565,690
-2.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#251
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearbridge Investments, LLC holds $3,156,802,100 across 12 Drug Manufacturers - General names. MRK ranks #5 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,343,260 | $1,357,027,741 | |
| 2 | AZN |
Astrazeneca PLC
|
5,021,518 | $952,180,243 | |
| 3 | LLY |
ELI LILLY & Co
|
483,528 | $579,958,037 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,088,957 | $137,578,827 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
565,690 | $72,691,165 | |
| 6 | AMGN |
Amgen Inc
|
69,065 | $25,009,817 | |
| 7 | ABBV |
AbbVie Inc.
|
82,422 | $20,740,672 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
101,597 | $5,854,019 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,691,165 | 565,690 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $69,501,877 | 577,786 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $63,195,051 | 600,371 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $417,172,972 | 4,970,487 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $387,176,863 | 4,891,067 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $532,248,435 | 5,929,684 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $578,289,375 | 5,813,122 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $775,672,033 | 6,830,504 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $852,554,766 | 6,886,549 | Shares | Defined | 2024-08-27 | |
| 2024-03-31 | $927,151,425 | 7,026,536 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $777,791,088 | 7,134,389 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $749,558,257 | 7,280,799 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $855,706,046 | 7,415,773 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $802,737,870 | 7,545,238 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $890,330,812 | 8,024,613 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $708,863,882 | 8,231,118 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $762,457,536 | 8,363,031 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $692,540,481 | 8,440,469 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $683,762,920 | 8,921,750 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $740,700,945 | 9,861,549 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $768,582,711 | 9,882,766 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $780,147,212 | 10,119,948 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $837,790,396 | 10,241,941 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $868,012,096 | 10,464,276 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $879,788,509 | 11,377,061 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $894,006,343 | 11,619,531 | Shares | Defined | 2020-05-22 | |
| No filing history on record for this holder in this stock. | ||||||